Eupraxia Pharmaceuticals prices $70M share offering

[finance and investment, currency exchange concept. Accountant using calculator with coins and financial report, economic graph growth, finance background, Business, accounting banking concept.]

* Eupraxia Pharmaceuticals (NASDAQ:EPRX [https://seekingalpha.com/symbol/EPRX]) priced [https://seekingalpha.com/pr/20240457-eupraxia-pharmaceuticals-announces-pricing-of-us-70-million-public-offering-of-common-shares] its previously announced public offering of 12.7M common shares at a price to the public of $5.50 per common share for gross proceeds of ~$70 million.
* In addition, the company has granted the underwriters a 30-day option to purchase up to an additional 1.9M common shares on the same terms and conditions.
* The offering is expected to close on September 24, 2025.
* Net proceeds are expected to be used for continued advancement of its product pipeline, including the completion of ongoing preclinical studies and clinical trials, regulatory submissions, and associated commercial preparation and manufacturing scale-up activities.

MORE ON EUPRAXIA PHARMACEUTICALS

* Historical earnings data for Eupraxia Pharmaceuticals  [https://seekingalpha.com/symbol/EPRX:CA/earnings]
* Financial information for Eupraxia Pharmaceuticals  [https://seekingalpha.com/symbol/EPRX:CA/income-statement]